首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials.
【24h】

The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials.

机译:骨关节炎的安慰剂作用及其决定因素:随机对照试验的荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To examine the placebo effect and its potential determinants in the treatment of osteoarthritis (OA) via a systematic literature search of Medline, EMBASE, Scientific Citation Index, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Library. METHODS: Randomised placebo controlled trials in OA were included. The placebo effect was defined as the overall change from baseline in the placebo group. It was estimated as the effect size (ES; the standard mean difference between baseline and endpoint) and this was compared with the ES obtained from untreated control. ES for pain was the primary outcome. Statistical pooling was undertaken as appropriate and 95% CIs were used for comparison. Quality of trials was assessed and potential determinants of placebo effect were examined using multiple regression analysis. The partial regression coefficient (beta) was used to present the adjusted size of the association. RESULTS: We identified 198 trials with 193 placebo groups (16 364 patients) and 14 untreated control groups (1167 patients) that met our inclusion criteria. These included a range of therapies (non-pharmacological, pharmacological and surgical treatments). Placebo was effective at relieving pain (ES 0.51, 95% CI 0.46 to 0.55 for the placebo group and 0.03, 95% CI -0.13 to 0.18 for untreated control). Placebo was also effective at improving function and stiffness. The pain-relieving effect increased when the active treatment effect (beta=0.38, p<0.001), baseline pain (0.006, p=0.014) and sample size (0.001, p=0.004) increased, and when placebo was given through injectionseedles (0.144, p=0.020). CONCLUSION: Placebo is effective in the treatment of OA, especially for pain, stiffness and self-reported function. The size of this effect is influenced by the strength of the active treatment, the baseline disease severity, the route of delivery and the sample size of the study.
机译:目的:通过系统检索Medline,EMBASE,科学引文索引,护理和相关健康文献累积索引(CINAHL)和Cochrane图书馆,探讨安慰剂在治疗骨关节炎(OA)中的作用及其潜在的决定因素。方法:纳入了OA的随机安慰剂对照试验。安慰剂作用定义为安慰剂组相对于基线的总体变化。估计为效应大小(ES;基线与终点之间的标准平均差),并将其与从未治疗对照获得的ES进行比较。 ES是疼痛的主要结局。进行了适当的统计合并,并使用95%CI进行比较。使用多元回归分析评估了试验的质量,并检查了安慰剂作用的潜在决定因素。使用偏回归系数(beta)来表示调整后的关联大小。结果:我们确定了198项试验,其中193个安慰剂组(16 364例患者)和14个未接受治疗的对照组(1167例)符合我们的纳入标准。这些包括一系列疗法(非药物,药物和外科治疗)。安慰剂可有效缓解疼痛(安慰剂组为ES 0.51,95%CI为0.46至0.55,未经治疗的对照组为0.03,95%CI -0.13至0.18)。安慰剂也有效改善功能和僵硬。当主动治疗效果(β= 0.38,p <0.001),基线疼痛(0.006,p = 0.014)和样本量(0.001,p = 0.004)增加以及通过注射给予安慰剂时,缓解疼痛的作用增强/针(0.144,p = 0.020)。结论:安慰剂可有效治疗OA,尤其是对疼痛,僵硬和自我报告的功能。这种作用的大小受有效治疗强度,基线疾病严重程度,分娩途径和研究样本量的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号